FDA Inspection 1257452 — UCB Biosciences Inc.
The FDA completed an inspection of UCB Biosciences Inc. on Sep 22, 2025 in Smyrna, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 22, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Smyrna, GA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)